BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Open|| Short (1M)
Nirmal Bang Recommends 'Accumulate' On Aurobindo Pharma
According to Nirmal Bang, earnings from its acquired operations will decline for Aurobindo Pharma over time. However, the company can divert its resources towards restructuring costs to ensure that the margins remain favourable, the brokerage adds.